Buy Star Health & Al Ins Co L, target price Rs 595: IIFL Securities

Best Stock to Buy Today : IIFL Securities has buy call on Star Health & Al Ins Co L with a target price of Rs 595. The current market price of Star Health & Al Ins Co L is Rs 566.

Buy Star Health & Al Ins Co L, target price Rs 595: IIFL Securities

IIFL Securities has issued a buy call on Star Health & Allied Insurance Company Limited (Star Health) with a target price of Rs 595, reflecting an upside potential of around 5% from the current market price of Rs 566. The brokerage firm believes that Star Health's strong market position, innovative products, and focus on digital transformation will drive its growth in the future. Star Health holds a leading position in the health insurance industry in India and has been consistently expanding its market share.

About Star Health & Al Ins Co L:

Star Health & Allied Insurance Company Limited (Star Health) is the largest private health insurer in India. The company offers a wide range of health insurance products to individuals, families, and businesses. Star Health was founded in 2006 and is headquartered in Chennai, India. The company has a network of over 10,000 hospitals and over 1 lakh agents across India. Star Health is a publicly traded company and its shares are listed on the National Stock Exchange of India (NSE).

52 Week Price Trend:

Star Health & Allied Insurance Company's current market price (CMP) stands at Rs 566. Over the past 52 weeks, the stock has experienced a high of Rs 675 and a low of Rs 507.5. This indicates a potential upside of approximately 19% from the current CMP to the 52-week high. However, it's important to note that past performance may not always be indicative of future results, and investors should carefully consider all relevant factors before making investment decisions.

Stratzy's MOST Analysis:

Stratzy's MOST Framework has assigned STARHEALTH a rating of BB-, indicating medium fundamental risks. This assessment considers the company's management, outlook, safety, and trend. The rating suggests that while STARHEALTH has some strengths, it also faces certain challenges in these key areas. Investors should exercise caution and conduct further due diligence before investing in this company.

Fundamental and Technical information provided in this blog were last updated on 20 Apr, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.